サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1368389

細胞培養培地・血清・試薬の世界市場 - 予測（～2030年）

Global Cell Culture Media Market Research Report - Forecast to 2030

出版日
ページ情報
英文 130 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
細胞培養培地・血清・試薬の世界市場 - 予測（～2030年）
出版日: 2023年10月10日
発行: Market Research Future
ページ情報: 英文 130 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞培養培地・血清・試薬の市場規模は、2030年までに188億米ドルに達し、CAGRで10.5%の成長が予測されています。バイオ医薬品の人気の向上や、慢性疾患の症例の増加、細胞培養技術を利用した治療への関心の高まりが、市場の発展を促進する見込みです。

地域の分析

南北アメリカが最大の市場規模を有しています。

欧州が2番目に大きい市場となり、アジア太平洋がそれに続く見込みです。アジア太平洋は市場でもっとも急速に発展しています。

当レポートでは、世界の細胞培養培地・血清・試薬市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 レポートプロローグ

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

  • 促進要因
  • 抑制要因

第5章 市場要因の分析

  • ポーターのファイブフォース分析モデル
  • サプライチェーン分析

第6章 世界の細胞培養培地・血清・試薬市場：タイプ別

  • 培地
    • 化学的に定義された培地
    • 無血清培地
    • 無タンパク質培地
    • 基礎培地
    • その他
  • 血清
    • ウシ胎児血清
    • 新生仔ウシ血清
    • その他
  • 試薬
    • 抗生剤
    • 生物学的洗剤
    • 生物学的緩衝液
    • 細胞生存率キット、試薬
    • その他

第7章 世界の細胞培養培地・血清・試薬市場：用途別

  • がん研究
  • ウイルス学
  • 毒性試験
  • ワクチン生産
  • 医薬品開発
  • その他

第8章 世界の細胞培養培地・血清・試薬市場：エンドユーザー別

  • 研究室
  • 学術機関
  • 病理学研究室
  • その他

第9章 世界の細胞培養培地・血清・試薬市場：地域別

  • イントロダクション
  • 南北アメリカ
    • 北米
    • 南米
  • 欧州
    • 西欧
    • 東欧
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • オマーン
    • クウェート
    • カタール
    • その他の中東・アフリカ

第10章 競合情勢

  • 製品のコスト
  • 主要企業の生産能力

第11章 企業プロファイル

  • PAN BIOTECH
  • MERCK KGAA
  • SIGMA ALDRICH
  • PFIZER INC
  • THERMOFISHER SCIENTIFIC
  • GENERAL ELECTRIC COMPANY
  • BIOWEST
  • LONZA AG
  • PROMOCELL GMBH
  • その他

第12章 結論

  • 主な調査結果
    • CEOの視点から
    • 市場のアンメットニーズ
  • 注目すべき主要企業
  • ライフサイエンス産業の予測

第13章 付録

図表

LIST OF TABLES

  • TABLE 1 MEDIA SERA & REAGENTS INDUSTRY SYNOPSIS, 2020-2027
  • TABLE 2 GLOBAL MEDIA SERA & REAGENTS MARKET ESTIMATES & FORECAST, 2020-2027, (USD MILLION)
  • TABLE 3 GLOBAL MEDIA SERA & REAGENTS MARKET, BY REGION, 2020-2027, (USD MILLION)
  • TABLE 4 GLOBAL MEDIA SERA & REAGENTS MARKET, BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 5 GLOBAL MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 6 GLOBAL MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION)
  • TABLE 7 AMERICAS MEDIA SERA & REAGENTS MARKET, BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 8 AMERICAS MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 9 AMERICAS MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION)
  • TABLE 10 NORTH AMERICA MEDIA SERA & REAGENTS MARKET, BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 11 NORTH AMERICA MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 12 NORTH AMERICA MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION)
  • TABLE 13 SOUTH AMERICA MEDIA SERA & REAGENTS MARKET, BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 14 SOUTH AMERICA MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 15 SOUTH AMERICA MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION)
  • TABLE 16 EUROPE MEDIA SERA & REAGENTS MARKET, BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 17 EUROPE MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 18 EUROPE MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION)
  • TABLE 19 WESTERN EUROPE MEDIA SERA & REAGENTS MARKET BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 20 WESTERN EUROPE MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 21 WESTERN EUROPE MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION)
  • TABLE 22 EASTERN EUROPE MEDIA SERA & REAGENTS MARKET, BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 23 EASTERN EUROPE MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 24 EASTERN EUROPE MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION)
  • TABLE 25 ASIA PACIFIC MEDIA SERA & REAGENTS MARKET, BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 26 ASIA PACIFIC MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 27 ASIA PACIFIC MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION)
  • TABLE 28 MIDDLE EAST & AFRICA MEDIA SERA & REAGENTS MARKET, BY TYPE, 2020-2027, (USD MILLION)
  • TABLE 29 MIDDLE EAST & AFRICA MEDIA SERA & REAGENTS MARKET, BY APPLICATION, 2020-2027, (USD MILLION)
  • TABLE 30 MIDDLE EAST & AFRICA MEDIA SERA & REAGENTS MARKET, BY END USER, 2020-2027, (USD MILLION) 

LIST OF FIGURES

  • FIGURE 1 RESEARCH PROCESS
  • FIGURE 2 SEGMENTATION FOR GLOBAL MEDIA SERA & REAGENTS MARKET
  • FIGURE 3 SEGMENTATION MARKET DYNAMICS FOR MEDIA SERA & REAGENTS MARKET
  • FIGURE 4 GLOBAL MEDIA SERA & REAGENTS MARKET SHARE, BY TYPE, 2020
  • FIGURE 5 GLOBAL MEDIA SERA & REAGENTS MARKET SHARE, BY APPLICATION, 2020
  • FIGURE 6 GLOBAL MEDIA SERA & REAGENTS MARKET SHARE, BY END USER, 2020
  • FIGURE 7 GLOBAL MEDIA SERA & REAGENTS MARKET SHARE, BY REGION, 2020
  • FIGURE 8 AMERICAS MEDIA SERA & REAGENTS MARKET SHARE, BY COUNTRY, 2020
  • FIGURE 9 EUROPE MEDIA SERA & REAGENTS MARKET SHARE, BY COUNTRY, 2020
  • FIGURE 10 ASIA PACIFIC MEDIA SERA & REAGENTS MARKET SHARE, BY COUNTRY, 2020
  • FIGURE 11 MIDDLE EAST & AFRICA MEDIA SERA & REAGENTS MARKET SHARE, BY COUNTRY, 2020
  • FIGURE 12 GLOBAL MEDIA SERA & REAGENTS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
目次
Product Code: MRFR/Pharma/0664-HCR

Market Overview

The media sera and reagents- cell culture market is projected to reach USD 18,800 Million by 2030 at 10.5% CAGR during the review period.

Cell culture is the way cells develop under controlled conditions outside the common habitat. In cell culture, the states of every cell type are unique, yet the fake climate comprises of a medium or reagents that give supplements to the cell.

The ascent of popularity for biotechnological and biopharmaceutical items, developing instances of expanding persistent illnesses, and the developing interest for treating utilizing cell culture techniques will drive the market's development. The higher interests in innovative work in biotechnology will emphatically impel the market's development. Numerous advancements in the field of rDNA innovation and drugs will animate the market's development. The capital venture for a Cell culture office is costly, which might obstruct the development of the market.

America possesses the biggest market because of extraordinary interest in innovative work in the biotech and pharma enterprises. The monetary circumstances for innovative work are considerably higher. The developing mindfulness among individuals and the presence of central members in this region will add to the development of the market.

Market Segmentation

Based on application, type, and end-user, the global media sera and reagents-cell culture market is divided into segments. The type segment is further divided into medium, sera, and reagents.

The media segment includes chemically defined media, serum-free media, protein-free media, traditional media, and others. The market based on sera is classified into fetal bovine serum, newborn calf serum, and various types of serum.

In terms of reagents the global sera, media, and cell culture market is further divided into antibiotics, biological detergents, biological buffers, cell viability kits and reagents, and others.

In terms of application, the global market is categorized into drug development, cancer research, toxicity testing, virology, vaccine development, and others based on applications.

The market is divided into pathology labs, academic institutions, research laboratories, and others by end users.

Regional analysis

America dominates the biggest market because of its immense interest in innovative work in biotech and pharma ventures and its monetary circumstances for innovative work. Rising mindfulness among individuals and the presence of many central members in this region have likewise contributed to the development of the market.

Europe is expected to become the second largest market for media sera and reagents-cell culture market followed by Asia Pacific. Because of the accessibility of assets for innovative work exercises and developing accentuation on research for treating sicknesses. Asia Pacific shows the quickest development in this market because of an expansion in commonness of transferable illnesses. For the most part, India and China are beginning use in innovative work areas of medical care space.

Key players

The major players in the media, sera and reagents-cell culture market are PAN biotech (Germany), Hi-media Laboratories (India), Sigma Aldrich (US), Thermofisher Scientific (US), Merck KGaA (Germany), Biowest (France), General Electric company (US), VWR International, Lonza AG (Switzerland), PromoCell GmbH, and others.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 REPORT PROLOGUE

2 MARKET INTRODUCTION

  • 2.1 INTRODUCTION
  • 2.2 SCOPE OF STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 ASSUMPTIONS & LIMITATIONS
    • 2.4.1 ASSUMPTIONS
    • 2.4.2 LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 RESEARCH PROCESS
  • 3.2 PRIMARY RESEARCH
  • 3.3 SECONDARY RESEARCH

4 MARKET DYNAMICS

  • 4.1 DRIVERS
  • 4.2 RESTRAINTS

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF NEW ENTRANTS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 SUPPLY CHAIN ANALYSIS

6. GLOBAL MEDIA SERA AND REAGENTS- CELL CULTURE, BY TYPE

  • 6.1 MEDIA
    • 6.1.1 CHEMICALLY DEFINED MEDIA
    • 6.1.2 SERUM-FREE MEDIA
    • 6.1.3 PROTEIN FREE MEDIA
    • 6.1.4 CLASSICAL MEDIA
    • 6.1.5 OTHERS
  • 6.2 SERA
    • 6.2.1 FETAL BOVINE SERUM
    • 6.2.2 NEW-BORN CALF SERUM
    • 6.2.3 OTHERS
  • 6.3 REAGENTS
    • 6.3.1 ANTIBIOTICS
    • 6.3.2 BIOLOGICAL DETERGENTS
    • 6.3.3 BIOLOGICAL BUFFERS
    • 6.3.4 CELL VIABILITY KITS AND REAGENTS
    • 6.3.5 OTHERS

7. GLOBAL MEDIA SERA AND REAGENTS- CELL CULTURE MARKET, BY APPLICATION

  • 7.1 CANCER RESEARCH
  • 7.2 VIROLOGY
  • 7.3 TOXICITY TESTING
  • 7.4 VACCINE PRODUCTION
  • 7.5 DRUG DEVELOPMENT
  • 7.6 OTHERS

8. GLOBAL MEDIA SERA AND REAGENTS- CELL CULTURE MARKET, BY END USERS

  • 8.1 RESEARCH LABORATORIES
  • 8.2 ACADEMIC INSTITUTIONS
  • 8.3 PATHOLOGY LABS
  • 8.4 OTHER

9. GLOBAL MEDIA SERA AND REAGENTS- CELL CULTURE MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 AMERICA
    • 9.2.1 NORTH AMERICA
      • 9.2.1.1 US
      • 9.2.1.2 CANADA
    • 9.2.2 SOUTH AMERICA
  • 9.3 EUROPE
    • 9.3.1 WESTERN EUROPE
      • 9.3.1.1 GERMANY
      • 9.3.1.2 UK
      • 9.3.1.3 FRANCE
      • 9.3.1.4 ITALY
      • 9.3.1.5 SPAIN
      • 9.3.1.6 REST OF WESTERN EUROPE
    • 9.3.2 EASTERN EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
    • 9.4.2 CHINA
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 REPUBLIC OF KOREA
    • 9.4.6 REST OF ASIA PACIFIC
  • 9.5 MIDDLE EAST & AFRICA
    • 9.5.1 UNITED ARAB EMIRATES
    • 9.5.2 SAUDI ARABIA
    • 9.5.3 OMAN
    • 9.5.4 KUWAIT
    • 9.5.5 QATAR
    • 9.5.6 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 COST OF PRODUCTS
  • 10.2 PRODUCTION CAPACITY OF MAJOR PLAYERS

11 COMPANY PROFILE

  • 11.1 PAN BIOTECH
    • 11.1.1 OVERVIEW
    • 11.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.1.3 FINANCIAL UPDATES
    • 11.1.4 KEY DEVELOPMENTS
  • 11.2 MERCK KGAA
    • 11.2.1 OVERVIEW
    • 11.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.2.3 FINANCIAL UPDATES
    • 11.2.4 KEY DEVELOPMENTS
  • 11.3 SIGMA ALDRICH
    • 11.3.1 OVERVIEW
    • 11.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.3.3 FINANCIAL UPDATES
    • 11.3.4 KEY DEVELOPMENT
  • 11.4 PFIZER INC
    • 11.4.1 OVERVIEW
    • 11.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.4.3 FINANCIAL UPDATES
    • 11.4.4 KEY DEVELOPMENT
  • 11.5 THERMOFISHER SCIENTIFIC
    • 11.5.1 OVERVIEW
    • 11.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.5.3 FINANCIAL UPDATES
    • 11.5.4 KEY DEVELOPMENTS
  • 11.6 GENERAL ELECTRIC COMPANY
    • 11.6.1 OVERVIEW
    • 11.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.6.3 FINANCIAL UPDATES
    • 11.6.4 KEY DEVELOPMENTS
  • 11.7 BIOWEST
    • 11.7.1 OVERVIEW
    • 11.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.7.3 FINANCIAL UPDATES
    • 11.7.4 KEY DEVELOPMENTS
  • 11.8 LONZA AG
    • 11.8.1 OVERVIEW
    • 11.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.8.3 FINANCIAL UPDATES
    • 11.8.4 KEY DEVELOPMENTS
  • 11.9 PROMOCELL GMBH
    • 11.9.1 OVERVIEW
    • 11.9.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 11.9.3 FINANCIAL UPDATES
    • 11.9.4 KEY DEVELOPMENTS
  • 11.9 OTHERS

12 CONCLUSION

  • 12.1 KEY FINDINGS
    • 12.1.1 FROM CEO'S VIEWPOINT
    • 12.1.2 UNMET NEEDS OF THE MARKET
  • 12.2 KEY COMPANIES TO WATCH
  • 12.3 PREDICTION OF LIFE SCIENCE INDUSTRY

13 APPENDIX